Quest Diagnostics (NYSE:DGX) Q3 2025 Earnings Call October 21, 2025 08:30 AM ET Company ParticipantsJim Davis - CEOShawn Bevec - VP of Investor RelationsSam Samad - CFOConference Call ParticipantsPito Chickering - AnalystAndrew Brackman - Equity Research AnalystPatrick Donnelly - AnalystKevin Caliendo - AnalystErin Wright - AnalystLuke Sergott - AnalystMichael Cherny - Equity Research AnalystElizabeth Anderson - Healthcare Equity Research AnalystMichael Ryskin - AnalystJack Meehan - AnalystTycho Peterson - ...

Quest Diagnostics (NYSE:DGX) Q3 2025 Earnings Call October 21, 2025 08:30 AM ET Speaker0Growth rates associated with our long term outlook projections including consolidated revenue growth, revenue growth from acquisitions, organic revenue growth and adjusted earnings growth are compound annual growth rates. Now here is Jim Davis. Thanks, Sean and good morningSpeaker1everyone. Our third quarter performance underscores strong demand for our clinical solutions, our diligent execution to meet customer needs an ...

Q3 2025 Performance Robust growth and strong demand for our clinical solutions enables Quest to again raise full year 2025 guidance Q3 2025 13.1% Total revenue $2.82 billion Adjusted operating Adjusted diluted EPS2 $2.60 per share 16.3% 13.0% 1,3 Company overview Quest is a leader in diagnostic testing insights and information services. Read our Q3 earnings press release on our Investor Relations site. We delivered another quarter of robust top- and bottom-line growth, underscoring strong demand for our cli ...